Difference between revisions of "Communications Committee"
Jump to navigation
Jump to search
| Line 25: | Line 25: | ||
'''Approved call summaries:''' | '''Approved call summaries:''' | ||
| − | *[[Media:2021_02_26_QCC_Call_Summary-FINAL-AMS.pdf | February 26, 2021]] | + | *[[Media:2021_02_26_QCC_Call_Summary-FINAL-AMS-2.pdf | February 26, 2021]] |
*[[Media:2021_01_29_QCC_Call_Summary-FINAL.pdf | January 29, 2021]] | *[[Media:2021_01_29_QCC_Call_Summary-FINAL.pdf | January 29, 2021]] | ||
Revision as of 15:45, 16 March 2021
- Chairs: Anne M. Smith, PhD; Majid Chalian, MD
- RSNA Staff Support: Julie Lisiecki
Communications Committee Mission Statement
QIBA Communications will educate and publicize the impact of image quantification on therapeutic and drug clinical trials and patient disease staging and follow-up.
- Oversee educational component
Scope
The Communications Committee supports QIBA Biomarker Committees by providing visibility to QIBA efforts.
QIBA Community
A QIBA Community has been set up via the Higher Logic platform on RSNA web pages to encourage continuing dialogue among QIBA members and across modalities. Instructions are available here:
Meetings/Call Summaries
Monthly Tcons (Contact Julie for details)
Approved call summaries: